MissionIRNewsBreaks – India Globalization Capital, Inc.’s (NYSE: IGC) Future Business Strategy

India Globalization Capital (NYSE American: IGC) is strategizing the marketing of its products and select target markets for continued growth. A recent article highlights next year’s and future year’s prospects and IGC plans, stating, “[IGC] sees opportunities in 2018, primarily from the distribution, in Germany, of its cannabinoid-based therapies, including IGC-AD1 (Hyalolex). It also sees the commercialization in 2018 of Hyalolex in a non-inebriating liquid supplement version. IGC has identified a number of U.S. states, as well as Canada and Germany, as target markets in the future.”

To view the full press release, visit http://dtn.fm/oBGy1

About IGC

IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats.  IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information, please visit www.IGCinc.us.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) Closes Acquisition of Nipissing Lorrain Mine Project

Quantum Cobalt (CSE: QBOT) (FRA: 23B) today announced that it has closed its previously announced acquisition of 1142674 BC Ltd. (the “Target”) in line with the share exchange agreement between Quantum Cobalt, the target and the shareholders of the target. Per the agreement, the company has acquired the Nipissing Lorrain Cobalt Project located near Cobalt, Ontario. The property consists of two separate claims and includes six distinct underground workings that have been historically mined for Cobalt-Silver-Nickel. Per the share exchange agreement, the company will pay a total amount of $1,000,000 over a six month period from date of close with an initial cash payment of $500,000 due on closing and $250,000 every three months after. Additionally, Quantum Cobalt will issue five million common shares to the shareholders of the target upon closing in exchange for one Class A common share in the capital of the target. “We are pleased to have added the Nipissing Lorrain Cobalt Project to our portfolio. Exploration plans on the Property will be conducted with a heightened level of confidence and commitment recognizing it was a past producer,” Quantum Cobalt CEO Greg Burns stated in the news release.

To view the full press release, visit http://dtn.fm/m3AuF

About Quantum Cobalt Corp.

Quantum Cobalt Corp. (formerly Bravura Ventures Corp.) is building one of the largest land packages in the prolific mining town of Cobalt, Ontario, Canada, with the option to acquire 100 percent of the Nipissing Lorrain Cobalt Property that includes two separate claims. The property, consisting of 29 claim units for approximately 464 hectares, is located in an historically mined area with rich deposits of cobalt, silver and nickel. The area is easily accessible by road with power and infrastructure nearby. For more information, visit the company’s website at www.QuantumCobalt.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Aims to Tackle Growing Global Demand for Lithium

Canadian energy exploration and development company Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) is poised to benefit from the rising lithium demand combined with the anticipated shortage from major producers. An article discussing this reads: “Even with major producers ramping up production, serious shortfalls are expected. Shortages can only be made up by junior miners like Standard Lithium Ltd. (TSXV: SLL) (FRA: S5L) (OTCQX: STLHF). Standard Lithium is rapidly assembling a prodigious portfolio of U.S. based lithium brine assets and actively engaged in the further exploration and development of its Bristol Lake, Brine Project located in the Mojave region of California.  Standard Lithium’s Bristol Lake project initially encompassed 16,600+ acres of placer mineral claims, but with the company’s recently announced MOU with Tetra Technologies, Inc. (NYSE: TTI), they have almost tripled the entire Bristol Dry Lake Lithium Project and now has up to 48,000 acres of placer mineral claims and private property lithium brine assets available for development.”

To view the full article, visit http://dtn.fm/O59wh

About Standard Lithium Ltd.

Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also commencing resource evaluation on 33,000 acres of brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Targets Nanoemulsions Market Through Collaboration with Phasex Corp.

Pressure BioSciences (OTCQB: PBIO) recently entered into a strategic collaboration with Phasex Corporation. The company’s goal is to combine its patented Ultra Shear Technology (“UST”) with Phasex’ Supercritical Fluid (“SCF”) processing to cultivate stable, water-soluble nanoemulsions. An article discussing this reads: “Emulsions are mixtures of two or more liquids (e.g., oils and water) that cannot be blended into each other without the addition of chemicals called surfactants. Emulsions represent an incredibly large existing market with a wide range of applications, including nutraceuticals, pharmaceuticals, cosmetics, industrial lubricants, paints and even food. Currently, most commercially-available emulsion products contain large oil droplets and high amounts of surfactants, which tend to make these macro- and micro-emulsions unstable and not suitable for human use. Conversely, scientific studies have shown that nanoemulsions (with very small oil droplet sizes) generally exhibit improved absorption, higher bioavailability, greater stability, lower surfactant levels and other clear advantages over macro- and micro-emulsions.”

To view the full article, visit http://dtn.fm/1yPfD

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

India Globalization Capital, Inc. (NYSE: IGC) Enters MOU for Distribution in Germany, Plans to Commercialize Liquid Formulation of Hyalolex

• IGC is scheduled to market a liquid formulation of its drug, IGC-AD1 (Hyalolex), in 2018; company is eyeing markets in Germany, Canada and U.S. states where licensed medical cannabis has been legalized
• IGC is exclusive licensee of a U.S. patent filing for possible THC-based Alzheimer’s disease (AD) therapy, which, if approved, could give it a huge advantage in competition for share of global drug market for AD
• Alzheimer’s Association: Some five million Americans have AD or some form of dementia, and $259 billion is being spent on treatments in 2017 — a number that could skyrocket to $1.1 trillion by 2050

India Globalization Capital, Inc. (NYSE American: IGC) sees opportunities in 2018, primarily from the distribution, in Germany, of its cannabinoid-based therapies, including IGC-AD1 (Hyalolex). It also sees the commercialization in 2018 of Hyalolex in a non-inebriating liquid supplement version. IGC has identified a number of U.S. states, as well as Canada and Germany, as target markets in the future.

The Maryland-based company is focused on the development of cannabis-based combination therapies to treat eating disorders, nausea, Alzheimer’s disease (AD), pain, and possibly Parkinson’s. It is also researching drugs that treat epilepsy in dogs and cats. The firm already has a portfolio of patent filings and four lead products that address these conditions.

IGC is the exclusive licensee of the U.S patent filing, “THC As A Potential Therapeutic Agent For Alzheimer’s Disease.” This gives IGC an advantage in the global market of AD drugs.

The global potential of AD treatment in massive. IGC sees worldwide application of its cannabinoid-based therapies (http://dtn.fm/3z2vD). In the U.S. alone, the Alzheimer’s Association estimates that treatment of AD and other forms of dementia will cost about $259 billion in 2017 — and that number could rise to $1.1 trillion by 2050 (http://dtn.fm/yTM4z). The Association said some five million Americans have AD today, and that number could rise to 16 million by 2050.

Because AD begins well prior to the appearance of symptoms, a drug such as IGC-AD1, which has shown an ability to lower production/aggregation of Aβ plaque without neurotoxic effects or inebriation, could be taken as a prophylactic treatment to prevent AD.

IGC has entered into a Memorandum of Understanding (MOU) with Hamburg, Germany-based MediCann Handels GMBH for the distribution of IGC’s cannabinoid-based therapies, including IGC-AD1, to pharmacies, apothecaries and other licensed outlets that can legally sell cannabinoid-based products (http://dtn.fm/t1Dg1). The MOU calls for MediCann to provide the capital required for the import, storage, transportation, sales and marketing of the products. In Germany, the number of dementia cases is 1.6 million-plus, most commonly caused by AD, per company data.

In a news release, Ram Mukunda, CEO of IGC, said the company would market, through medical dispensaries, a non-inebriating liquid supplement version of IGC-AD1 in 2018, with target markets spanning Germany, Canada and certain states within the U.S. Cumulatively, these markets have some 7.8 million patients with AD, the company said (http://dtn.fm/U0Cm8).

For more information, visit the company’s website at www.IGCinc.us

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) Completes First Pass Exploration on Ontario Project Near Temagami

Quantum Cobalt Corp. (CSE: QBOT) (FRA: 23B) today announced that its field crew finished a first pass exploration program on the Kahuna Cobalt Property. The property lies in the famous ‘Cobalt’ province and is approximately 37km south of the town of Cobalt, Ontario. Prior sampling recorded values of up to 22% cobalt from the waste rock on the property. 28 rock samples and 166 soil samples were collected on the project with pending results.

To view the full press release, visit http://dtn.fm/7SCxp

About Quantum Cobalt Corp.

Quantum Cobalt Corp. (formerly Bravura Ventures Corp.) is building one of the largest land packages in the prolific mining town of Cobalt, Ontario, Canada, with the option to acquire 100 percent of the Nipissing Lorrain Cobalt Property that includes two separate claims. The property, consisting of 29 claim units for approximately 464 hectares, is located in an historically mined area with rich deposits of cobalt, silver and nickel. The area is easily accessible by road with power and infrastructure nearby. For more information, visit the company’s website at www.QuantumCobalt.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Pressure BioSciences Inc. (PBIO) Forms Strategic Collaboration with Phasex Corporation to Address Markets for Nanoemulsions

• Goal is to combine PBIO’s patented Ultra Shear Technology (UST) with Phasex’ Supercritical Fluid (SCF) processing to develop stable, water-soluble nanoemulsions
• As part of this collaboration, PBIO and Phasex seek to develop stable, water-soluble nanoemulsions of nutraceuticals, including CBD-enriched plant oil
• CEO of PBIO sees collaboration leading to a ‘Value-add’ for Phasex customers and a highly profitable service model for both PBIO and Phasex

Pressure BioSciences Inc. (OTCQB: PBIO) recently announced a strategic collaboration with Phasex Corporation to develop stable, water-soluble nanoemulsions of nutraceuticals (http://dtn.fm/IWq4E). These nanoemulsions may exhibit improved absorption, greater stability, higher bioavailability and other strategic and medical advantages. The collaboration involves combining PBIO’s patented Ultra Shear Technology (UST) with Phasex’s Supercritical Fluid (SCF) extraction technology.

Emulsions are mixtures of two or more liquids (e.g., oils and water) that cannot be blended into each other without the addition of chemicals called surfactants. Emulsions represent an incredibly large existing market with a wide range of applications, including nutraceuticals, pharmaceuticals, cosmetics, industrial lubricants, paints and even food. Currently, most commercially-available emulsion products contain large oil droplets and high amounts of surfactants, which tend to make these macro- and micro-emulsions unstable and not suitable for human use. Conversely, scientific studies have shown that nanoemulsions (with very small oil droplet sizes) generally exhibit improved absorption, higher bioavailability, greater stability, lower surfactant levels and other clear advantages over macro- and micro-emulsions.

Many nutraceuticals begin as compounds contained in plants. When extracted, these compounds end up in the resulting plant oil. From there, they can be used as an oil or turned into an emulsion. Although there are many ways to extract specific compound-rich plant oil, SCF processing is generally considered the cleanest, safest and most environmentally-friendly method available today. Phasex has been using SCF processing for the extraction of compounds-of-interest from plants for over 40 years, and it is considered to be one of the U.S.’s foremost SCF extraction companies.

In a news release announcing the collaboration, Dr. Val Krukonis, a pioneer in SCF extraction and the founder of Phasex, said, “We are impressed with the potential of UST as a complementary technology to SCF extraction. Several customers are currently seeking new methods to turn hydrophobic oil extracts into stable, water-soluble formulations. UST offers the potential to solve this problem by producing stable nanoemulsions of oil-like products in water. Such formulations could potentially have enormous success in many markets, including inks, industrial lubricants, and cosmetics, as well as in pharmaceuticals and nutraceuticals, such as medically important plant oil extracts.”

Richard T. Schumacher, president and CEO of PBIO, added that, “We believe the ability to subject liquids to UST following the Phasex SCF extraction and purification process would be a highly sought-after ‘Value-add’ for Phasex customers. Rapidly-expanding markets for non-psychoactive extracts of cannabis plant material, for instance, is an example of a potentially high demand application for our combined, synergistic technologies.” He noted that the collaboration could potentially result in a highly profitable service model for both PBIO and Phasex.

Dr. Edmund Ting, Senior Vice President of Engineering for PBIO, explained that nanoemulsions are currently the focus of research efforts worldwide. “Unfortunately, even with these increased efforts, scale-up to a cost-effective, industrial level nanoemulsion production process remains a significant challenge. To that end, we believe that UST has the potential to work through those challenges, and to become a cost-effective, industrial-level nanoemulsion commercial process,” he noted.

As potentially explosive as UST seems to be, though, it is not the only disruptive technology upon which investors in PBIO need to hang their hat or their potential for future returns on investment. PBIO is also seen disrupting the “cell lysis” market (http://dtn.fm/pCaa4) with one of its new high-tech instruments, the Barocycler 2320EXT, which splits cells, according to the site Equities.com. This product carefully cracks open cells at precise pressures to extract the DNA, RNA, proteins and lipids inside in a safe, exquisitely controlled and highly reproducible manner. All the while, care is taken to minimize the damage to the cell’s constituents in order to make them available to research scientists in the highest quality possible. After all, the results of scientific studies are only as good as the quality of the starting material (DNA, proteins, etc.). Equities.com added that the company’s innovative line of instruments and consumables, based on its patented pressure cycling technology (PCT) platform, could revolutionize how researchers approach their studies. The cell lysis global market is projected to grow to $3.84 billion by 2021, showing a compound annual growth rate (CAGR) of 10.3% from 2016, according to a report by MarketsAndMarkets (http://dtn.fm/hQ2yg).

Pressure BioSciences recently announced record revenue for Q3. See the full news release at http://dtn.fm/BsrK9

For more information, visit the company’s website at www.PressureBiosciences.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Mobile Transaction Powerhouses Drive Moxian, Inc.’s (NASDAQ: MOXC) Plan for Growth in China

China’s Union Pay, Alipay and WeChat Pay mobile payment modules have been integrated into Moxian’s (NASDAQ: MOXC) social network for businesses and their clients, providing to Moxian significant resources to establish revenue growth. An article discussing this reads: “Alipay is a third party mobile and online payment module targeted to merchants, such as Macy’s, Neiman-Marcus, and Air Asia … Forbes quoted Analysys as reporting that WeChat Pay had 54% of the market in 1Q2017 (http://dtn.fm/mjZB4). The important thing for Moxian is that the two of them combined have a total of 94% of the mobile transaction market, which was valued at more than $5 trillion in 2016 by Mary Meeker’s 2017 Internet Trends Report.”

To view the full article, visit http://dtn.fm/ms4Sz

About Moxian, Inc.

Founded in 2013 in Shenzhen, China with branch offices in Beijing, Malaysia, and Hong Kong, Moxian, Inc. is an offline-to-online (O2O) integrated platform operator. The company’s “Moxian+” mobile App platform connects users to merchant clients through games, rewards and social events that they enjoy and in return, users provide valuable information that merchant clients can use to effectively promote products and services offered at their brick and mortar stores. For more information, visit the company’s website at www.Moxian.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Expanding Assets to Exploit Global Lithium Imbalance

• Major lithium producers not expected to make up impending shortfalls
• Standard Lithium nearly triples lithium assets to meet demand
• Company expediting activities to exploit global imbalance

The increasing demand and value of lithium have been reflected in the performance of lithium mining stocks over the last year. Lithium stocks have rocketed over the last twelve months propelled by insatiable demand for the alkali metal. Lithium has a broad range of industrial applications, from lubricants to glass and ceramics, alloys for lightweight metals, and now, progressively more, in Li-ion batteries.

Sixty percent of lithium use was used in industrial non-battery applications in 2015 while 25% was used in traditional batteries and fourteen per consumed for use in electric vehicles. Energy storage and e-bikes used less than 1% of output. A 2016 Deutsche Bank Markets Research Report (http://dtn.fm/Q66Fw) projected demand for 2025 is much different, not only in overall demand tonnage, but the percentages each application encompasses. By then the majority of lithium (38%) will be consumed by electric vehicles, 6% used for energy storage, and 14% for e-bikes. It’s no wonder that lithium demand has been projected to grow over 300% in the next six years.

Even with major producers ramping up production, serious shortfalls are expected. Shortages can only be made up by junior miners like Standard Lithium Ltd. (TSXV: SLL) (FRA: S5L) (OTCQX: STLHF). Standard Lithium is rapidly assembling a prodigious portfolio of U.S. based lithium brine assets and actively engaged in the further exploration and development of its Bristol Lake, Brine Project located in the Mojave region of California.  Standard Lithium’s Bristol Lake project initially encompassed 16,600+ acres of placer mineral claims, but with the company’s recently announced MOU with Tetra Technologies, Inc. (NYSE: TTI), they have almost tripled the entire Bristol Dry Lake Lithium Project and now has up to 48,000 acres of placer mineral claims and private property lithium brine assets available for development.

Comprehensive geophysics gravity surveys over the Bristol Lake Project indicate potentially high concentrations of lithium-bearing brines present throughout the company’s mineral lease agreement claims and expansion of nearby assets are expected to produce equally promising results. With permits already in place for extensive brine extraction and processing, Standard Lithium is expediting activities to exploit the huge imbalance and meet the urgent need for new lithium sources.

With enormous market imbalances unlikely to be rectified by major producers, investors interested in riding the lithium wave should consider junior miners like Standard Lithium for potential significant capital appreciation.

For more information about the company, visit http://nnw.fm/standardlithium

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Q3 Top Line Marks Record Quarterly Growth

Pressure BioSciences (OTCQB: PBIO) capitalized on a strong demand for its proprietary pressure-based laboratory instruments and related products, reporting record quarterly revenues of more than $600,000 for Q32017. An article discussing this reads: “Among recent highlights of the company’s operations, Pressure BioSciences set up its first Center of Excellence in Asia, which should have a marked impact on PBIO’s expansion into China. PBIO’s penetration into Europe is also expected to increase in the wake of multiple scientific presentations made throughout the continent over the past few months, some by key opinion leaders in the proteomics space.”

To view the full article, visit http://dtn.fm/CI0Ic.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Moxian, Inc. (NASDAQ: MOXC) Targets Four Key Cities in China, Eyes Revenue Growth

• Shanghai, Beijing, Shenzhen and Guangzhou are metropolitan markets targeted for MOXC’s growth
• China’s population is the world’s largest; goal is to convert its Moxian+ Business and Moxian+ User app platforms from free to paid
• Report: 1.39 billion mobile phone users registered in China, makes it largest globally

Moxian, Inc. (NASDAQ: MOXC) is targeting four key cities in China as it seeks new revenue streams from its two paid app platforms: Moxian+ Business and Moxian+ User. It seeks sales from subscriptions to these apps. Revenue streams also include financial processing commissions through its UnionPay module and, to its business clients in the Online-to-Offline (O2O) market, sales of sophisticated purchase analytics defining targeted and customized online advertising opportunities.

As it seeks to bring its Moxian+ User consumers closer to its Moxian+ Business clients, MOXC finds that these large metropolitan cities provide valuable mobile app businesses and consumer purchasers in the O2O market. That market is estimated this year at $78.4 billion, according to iResearch (http://dtn.fm/x6buA).

MOXC’s two Moxian apps were formerly free — now they are being converted to paid, designed to drive revenues as well. MOXC is a Shenzhen, China-based development stage company, which is aiming to convert its Moxian+ Business app clients from free to paid. It offers to consumers on the Moxian+ User app social media platforms, games and offers prizes in its own Mo-Points and Mo-Coins.

MOXC is focusing on major metropolitan cities in China to achieve its goals: Shenzhen, Beijing, Shanghai and Guangzhou. These population centers are key to marketing to mobile users in China’s enormous population. More important for MOXC, it is the biggest global mobile phone market with 1.39 billion registered users, according to research firm Statista® (http://dtn.fm/nLqH2).

Shenzhen is located in Southern China and has a population of nearly 10.8 million. It is a major financial center and has a modern communication, trade and transportation infrastructure. It houses a Special Economic Zone in China and is home to a number of hi-tech companies. To MOXC, it is a perfect place to market its apps that bring consumers and businesses together. It is one of China’s wealthiest cities.

With a population of 21.5 million as of 2016, Beijing is one of the country’s fastest-growing and wealthiest cities. Its high rise buildings and large population make it a sophisticated metropolitan market — a perfect target for MOXC to market its Moxian+ Business and Moxian+ User apps. Online delivery services, like those in the Moxian+ apps, thrive in this demographic.

Shanghai is China’s largest city, at once a financial hub and a draw for tourists. It had a population of 24.2 million in 2015 and communications and information systems have flourished here. Businesses — such as those attracted by the paid MOXC+ Business app — range from restaurants to entertainment.

Guangzhou has an economy driven by private business. It has a highly-educated population, which bodes well for sophisticated mobile phone apps and the success of the O2O market. Retail sales are growing in the double digits and it has an extensive manufacturing base.

For more information, visit the company’s website at www.Moxian.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Reports Q2 2018 Financial Results

India Globalization Capital (NYSE American: IGC) today reported financial results for the second quarter ended September 30, 2017, as well as an overview of recent operational highlights. The company’s legacy division which consists of rental of heavy equipment, commodities trading, and real estate management delivered revenue of $235,648 for the three months ended September 30, 2017, a sharp increase compared to $162,163 for the three months ended September 30, 2016.  The increase was primarily driven by increased volume of business. At the end of the second quarter, the company’s cash and cash equivalents along with restricted cash was $597,026 and working capital of $803,769. IGC expects to raise money for the canna-pharmaceutical business, specifically to immediately begin marketing IGC-AD1. Additionally, IGC reported its progress made on its six provisional patent filings in the phytocannabinoid-based combination therapy space for the indications of pain, medical refractory epilepsy, and cachexia. “Independent of our longer-term FDA clinical trial process, our near-term goal is to commercialize our liquid formulation for Alzheimer’s as a Complimentary and Alternative Medicine (CAM) sold through licensed medical cannabis dispensaries in the U.S., and internationally in Canada and Germany,” IGC CEO Ram Mukunda stated in the news release.

To view the full press release, visit http://dtn.fm/Jee7h

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Moxian, Inc.’s (NASDAQ: MOXC) Three-Way Strategy for Growing in China’s $5 Trillion Mobile Pay Market

• Moxian’s integrated platforms offer merchant clients recognized methods of mobile payment processing in AliPay and WeChat Pay, as well as UnionPay for ATMs and bank card services
• AliPay and WeChat Pay have a combined 94% of the mobile pay market in China, according to Forbes
• The mobile app market in China has surpassed $5 trillion annually, per industry data

Moxian, Inc. (NASDAQ: MOXC) has integrated its new paid platforms, Moxian+ Business and Moxian+ User, with China’s Union Pay, Alipay and WeChat Pay. The move sets the stage for new revenue growth as Moxian’s digital platforms are customized for monetization of payments throughout key markets in China, including Beijing, Shenzhen and Guangzhou.

Moxian is an integrated social media platform operator converting to paid its two formerly-free Moxian+ apps. It connects users to merchant clients through games, rewards and social events. Mo-Point and Mo-Coin rewards are also offered by the company.

Alipay is a third party mobile and online payment module targeted to merchants, such as Macy’s, Neiman-Marcus, and Air Asia (http://dtn.fm/sU2lN). It is owned and operated by technology company Ant Financial. It is estimated that AliPay has 54% of the mobile payments market in China (http://dtn.fm/1qJLc).

WeChat Pay has another 40% of the Chinese mobile market, a study by Hillhouse Capital quoted by CNBC showed. Forbes quoted Analysys as reporting that WeChat Pay had 54% of the market in 1Q2017 (http://dtn.fm/7s0Jl). The important thing for Moxian is that the two of them combined have a total of 94% of the mobile transaction market, which was valued at more than $5 trillion in 2016 by Mary Meeker’s 2017 Internet Trends Report. Analysys, quoted by Hillhouse Capital, projected that this market doubled to $5 trillion in 2016.

Besides these two major processors, Moxian also offers merchant clients a UnionPay module. UnionPay is a significant payment processor of credit cards charged by consumers in the online-to-offline market in China, and, globally, it owns some 25% of the credit card market, third only to Visa and MasterCard (http://dtn.fm/4hHcr). It also has a presence in some 160 countries worldwide, including the United States. Sales from Moxian apps processed by UnionPay earn Moxian an additional revenue stream.

For more information, visit the company’s website at www.Moxian.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Pressure BioSciences, Inc. (PBIO) Achieves Record Quarterly Revenue Growth

• Quarterly total revenue exceeds $600,000 for the first time ever
• Consumable sales up 158 percent year-over-year
• New Center of Excellence in Asia expected to speed expansion in China
• Recently patented Ultra Shear Technology platform can be used to create or improve a wide range of medical, consumer, and industrial products, through the preparation of high quality, stable nanoemulsions

Pressure BioSciences, Inc. (OTCQB: PBIO) has announced that it experienced record growth in total quarterly revenue during the third quarter of 2017, driven by continued strong instrument sales, and by a 158 percent increase in consumable sales, which is also a quarterly record (http://dtn.fm/oa0A0).

PBIO makes and markets its proprietary pressure-based lab instruments and related products to the life sciences industry for a wide range of activities involving sample preparation, a critical part of the preparatory work for almost all scientific analysis, and for the growing nanoemulsions market based on two recently issued patents and a strategic collaboration agreement with Phasex Corporation.

“We believe the revenue growth reported in the third quarter and year-to-date will not only continue in Q4 2017 and beyond, but will accelerate to an even greater rate as our new sales team begins to meet with existing and potential customers throughout the U.S. To that point, Q4 2017 Purchase Orders and Purchase Indications (90% estimated probability of closing) through early November have already exceeded products & services revenue for the full 2016 fourth quarter,” Joseph L. Damasio, Jr., VP of Finance and CFO, stated in a news release announcing the results.

The company’s product gross profit margin remained steady at about 47 percent, according to the news release. PBIO’s total revenue increased from $535,334 in the third quarter of 2016 to $646,061 in the same quarter for 2017. The company also saw record quarterly growth in products and services revenue of 21 percent.

Among recent highlights of the company’s operations, Pressure BioSciences set up its first Center of Excellence in Asia, which should have a marked impact on PBIO’s expansion into China. PBIO’s penetration into Europe is also expected to increase in the wake of multiple scientific presentations made throughout the continent over the past few months, some by key opinion leaders in the proteomics space.

The company and Phasex Corporation recently announced a cooperative agreement on nanoemulsions technology that will help them advance the delivery of unprecedented shelf-stable mixtures to deal with demands in food, nutraceutical, pharmaceutical, cosmetic, ink, paint, and lubricant markets. The company also received the first two patents issued for its high pressure-based Ultra Shear Technology (“UST”).

Pressure BioSciences held an earnings teleconference call Nov. 14 and has made a replay of the call available for the next 30 days by calling (877) 481-4010 in North America or (919) 882-2331 in other countries. The replay ID Number is 22751.

“We have spent a lot of time and money over the past few years preparing for this opportunity. We believe we are ready and taking all necessary actions to grow our momentum and fully exploit the exciting growth and new markets potential that we have long envisioned,” company President and CEO Richard T. Schumacher stated in the news release.

For more information, visit the company’s website at www.PressureBioSciences.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)

Atlanta, Georgia

www.MissionIR.com

404.941.8975 Office

Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Releases Results of Annual Shareholders Meeting

India Globalization Capital, Inc. (NYSE American: IGC) yesterday announced that during its 2016-2017 Annual Meeting of Shareholders on November 8, 2017, voting on Proposals Three and Four was adjourned to November 22, 2017 at 11:00 a.m. EST due to the lack of required stockholders needed. Stockholders of record on October 5, 2017 are eligible and requested by IGC to vote on these proposals that are available in the company’s proxy statement filed with the Securities and Exchange Commission (http://dtn.fm/aC1rD). Eligible stockholders may vote at www.ProxyVote.com, by dialing 800-454-8683, or by returning a properly executed proxy card to InvestorCom. The following proposals were approved at the annual meeting: (i) the election of Sudhakar Shenoy and Ram Mukunda as directors, (2) the proposal to ratify AJSH & Company as the company’s independent registered public accounting firm for the 2018 fiscal year, (3) the adoption of the company’s 2018 Omnibus Incentive Plan, (4) a non-binding advisory resolution to approve the compensation of the company’s named executive officers, and (5) approval to adjourn the meeting.

To view the full press release, visit http://dtn.fm/LN8jZ

About IGC

IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats.  IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information please visit www.IGCinc.us.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Posts Q3 2017 Financial Results, Provides Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”) reported financial results for the third quarter of 2017 today, along with a business update and limited guidance regarding its expected revenue for the rest of FY 2017. Among other highlights, the company reported a record-breaking total revenue of $646,061, an increase of 21% from $535,334 in the third quarter of 2016. The company also gained increases in products & services revenue, consumable sales and grant revenue. During the quarter, PBI also completed the hiring of its new 5-person field sales team and filled its Director of Sales North America position. “We believe the revenue growth reported in the third quarter and year-to-date will not only continue in Q4 2017 and beyond, but will accelerate to an even greater rate as our new sales team begins to meet with existing and potential customers throughout the U.S.,” PBI VP of finance and CFO Joseph L. Damasio, Jr. stated in the news release. Additionally, PBI will be holding a conference call to discuss the financial results today at 4:30pm EST. To join the conference, dial the North American number, (877) 407-8031 or the international number, (201) 689-8031. The verbal passcode will be “PBIO Third Quarter 2017 Financial Call.” The call will also be available for replay on the company’s website.

To view the full press release, visit http://dtn.fm/YJ5kc

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Names New Scientific Advisory Council Member, Craig Brown P.Eng.

Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) this morning announced it has appointed Craig J. Brown, P. Eng., to the company’s Scientific Advisory Council, effective immediately. Brown is a highly respected hydrometallurgical expert with over 45 years of experience in the field. Additionally, the company has initiated the first phase of test work on a new lithium-selective Ion Exchange (“IX”) resin that has been in development for numerous years by a major supplier of Li-specific IX resins. This testing expands and supplements Standard Lithium’s current testing program. “Craig brings extensive and well-respected expertise in selective ion-exchange and hydrometallurgical technologies, and will be instrumental in developing modern process flowsheets as the company continues its test work on lithium brines sourced from the company’s projects in the Bristol Dry Lake basin in the Mojave Desert of California and the Smackover Formation of Arkansas,” Standard Lithium president and COO Dr. Andy Robinson stated in the news release.

To view the full press release, visit http://dtn.fm/0sV0c

About Standard Lithium Ltd.

Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also commencing resource evaluation on 33,000 acres of brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Penetrates Key Markets in China with Paid Platforms

Online-to-offline (O2O) integrated platform operator Moxian, Inc. (NASDAQ: MOXC) is successfully targeting key markets in China with its paid platforms, resulting in various revenue streams. An article discussing this reads: “Key to MOXC’s unique attractiveness is its built-in UnionPay digital money collection process app — a highly desired feature by merchants (http://dtn.fm/E9qBe). That processing also provides a revenue stream to MOXC on every transaction. UnionPay is the dominant player in China’s digital payments system, the Crystal Equity Research report indicated, and it owns 25% of the global market for credit cards with a presence in 160 countries worldwide, including the U.S.”

 To view the full article, visit http://dtn.fm/6cTJW

About Moxian, Inc.

Founded in 2013 in Shenzhen, China with branch offices in Beijing, Malaysia, and Hong Kong, Moxian, Inc. is an offline-to-online (O2O) integrated platform operator. The company’s “Moxian+” mobile App platform connects users to merchant clients through games, rewards and social events that they enjoy and in return, users provide valuable information that merchant clients can use to effectively promote products and services offered at their brick and mortar stores. For more information, visit the company’s website at www.Moxian.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

EquityFeed Trading Platform Receives High Marks from Users

Your success as a profitable trader revolves around three primary factors: opportunities, timing and information. Designed with these factors in mind, EquityFeed’s real-time trader workstation helps traders rapidly weed through options based on up-to-the-minute and fully customized results.

Pattern recognition technology allows traders to cut through the noise of the market for a more focused approach. Subscribers can set-up filters and organize alerts according to a variety of preferences such as exchange, price, volume or other key technical variants. The result is a superior level of opportunity that revolutionizes the way traders monitor the market.

Don’t just take it from us; check out some of the testimonials on the EquityFeed site:

“I only trade penny stocks and there is no better Level 2 quote screen for OTC and Pinks than EquityFeed. Period. The activity log is like watching a play by play in plain English and has been a huge factor in me interpreting the Level 2 action.” – Craig Anderson

I really love that in addition to watching the live quotes for my personal stocks I also see any news or material events on those stocks in plain sight.” – Mary Hilden

“Equityfeed is all about productivity for me and these personal alerts make sure I’m notified whenever a particular stock I own or want to own has an important event.” – Joan Crawford

“When it’s time to zero in on a particular stock trade… efficient decision-making is extremely important to me. Chart Montage gives me the 360 degree view I need on any stock to make quick, accurate and confident decisions during pre trade and post trade.” – Richard Krantz

These are just a few of many customer reviews. Of course, there’s no better review than first-hand experience. To try it out yourself, visit http://dtn.fm/equityfeed and sign up for a 14-day trial.

OTC Markets Group Inc. (OTCM) Announces New Stock Promotion Policy and Sets Best Practices to Achieve Market Transparency

• A new “promotion risk flag” designation will be introduced on websites in the first quarter of 2018 to warn market participants of potential risks of trading a security during a promotion campaign
• Best practices are codified, listing the obligations of public companies to create transparency for investors
• The goal is also to identify ‘bad actors’ who mislead investors, disrupt pricing mechanisms of OTC markets and fraudulently promote campaigns that harm the integrity of public markets

OTC Markets Group Inc. (OTCQX: OTCM) has released a new stock promotion policy in conjunction with proposed established best practices for public companies (http://dtn.fm/X6meG). The goal is to ensure transparency for investors and better address the problem of fraudulent stock promotion. The new policy and best practices codify core principles of OTC Markets’ disclosure-based philosophy.

OTC Markets Group Inc. operates the U.S. and global securities that trade on the OTCQX® Best Market, the OTC® Venture Market and the Pink® Open Market. Its Issuer Compliance team is Washington, D.C.-based. It is responsible for compliance with OTCQX and OTCQB qualifications and ensuring transparency among the 10,000 U.S. and global securities that trade on its exchanges.

It also works to allow issuers to provide adequate current information to the marketplace. Issuer Compliance is engaged in continuous information sharing with the Financial Industry Regulatory Authority (FINRA), the SEC, other regulators and the exchanges.

Fraudulent stock promotion is an industry-wide concern that can mislead investors and disrupt the pricing mechanisms of OTC markets and national exchanges. Anonymous market manipulators can abuse today’s technology-driven environment, fraudulently promoting campaigns that harm the integrity of public markets. These practices can also impede the capital formation process with the potential of harming the reputation of small companies.

The goal of the new policy and list of best practices is to drive greater transparency while educating investors and mitigating the damage caused by manipulative stock promotion. A new “promotion risk flag” designation on OTC Markets Group websites is designed to alert market participants of potential risks associated with trading a security during a promotion campaign. The “promotion risk flag” designation will be introduced in the first quarter of 2018.

“We believe the SEC should modernize its promotion regulations to ban anonymous, paid stock promotion and require clear disclosure when there is promotion paid for by third-parties, allowing for markets to better identify market manipulators,” R. Cromwell Coulson, president and CEO, OTC Markets Group, noted in a news release.

The concept is to identify bad actors hiding among the private financing markets and accelerate real-time enforcement. OTC Markets Group outlines the obligations of issuers. These include publicly identifying securities being promoted, singling out fraudulent promotion campaigns and conforming to Best Practices for Issuers.

Liz Heese, OTC Markets Group Executive Vice President of Issuer and Information Services, explained that “investor transparency” is important for reputable public companies, and they need to proactively address and dispel unfounded rumors and correct that misinformation. “Our goal is to provide the framework of best practices that will foster better informed and more efficient public markets,” she said.

For more information, visit the company’s website at www.OTCMarkets.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) to Host Teleconference Regarding Q3 2017 Financial Results

Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, announced this morning that the company will host a conference call, during which the company will provide a business update and discuss financial results for the third quarter of 2017. The call will include a presentation by the company followed by a Q&A period. The call will take place November 14 at 4:30pm EST. To join the conference, dial the North American number, (877) 407-8031 or the international number, (201) 689-8031. The verbal passcode will be “PBIO Third Quarter 2017 Financial Call.” The call will also be available for replay on the company’s website.

To view the full press release, visit http://dtn.fm/0rpJs

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Moxian, Inc.’s (NASDAQ: MOXC) New Strategies Behind Potential Revenue Growth, Investor Confidence

• Penetrating key markets in China efficiently with paid platforms generating multiple revenue streams seen as key to its success
• Joint venture with fine wine marketer and distributor Shewn International Group, based in Shanghai, seen as beginning of low-cost and quick way to gain market share, Crystal Equity Research report finds
• Crystal Equity projects that the company will do $2.3 million in FY2018

Moxian, Inc. (NASDAQ: MOXC) has adopted two new dual strategies for growth: penetrating the online-to-offline (O2O) market by entering joint ventures and selling $2 million-$4 million retail businesses. The efforts to reach customers in key China markets quickly and at low cost can drive its success, Crystal Equity Research indicated in an August 2017 report (http://dtn.fm/5oZJz).

Moxian is a Shenzhen, China-based company that is executing its strategy of converting its two platforms — Moxian+ Business and Moxian+ User apps — in the O2O market from unpaid to paid (http://dtn.fm/n6qpX). This would launch numerous revenue streams:  transaction fees of 1% of all processing by UnionPay on these apps, subscription revenue, mobile advertising income, licensing fees, plus OEM fees. Moxian is an integrated platform operator and an early-stage company.

One of the changes the company has made to its overall strategy is to target larger retail businesses, those doing $2 million to $4 million in annual sales, rather than the small and medium sized enterprises (SMEs) it focused on prior.

Key to MOXC’s unique attractiveness is its built-in UnionPay digital money collection process app — a highly desired feature by merchants (http://dtn.fm/IG9aU). That processing also provides a revenue stream to MOXC on every transaction. UnionPay is the dominant player in China’s digital payments system, the Crystal Equity Research report indicated, and it owns 25% of the global market for credit cards with a presence in 160 countries worldwide, including the U.S.

The report adds that the Shewn International Groups’ Memorandum of Understanding (MOU) signed by Moxian is critical in assessing its future performance and gaining investor confidence.  “We view it as an important catalyst for valuation,” the Crystal report concluded. Shewn International Group is a distributor of fine wines. It has plans within China to market its wines in luxury apartments and other high end locations via self-pay elaborate vending machines, which keep the wines at precise temperatures. It hopes to install some 500,000 of the machines throughout the country, the report said. Under the agreement, the two companies would share technology and market strengths.

For more information, visit the company’s website at www.Moxian.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Fast-Tracks Project Development Schedule through Strategic Partnerships

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF), an energy exploration and development company, remains focused on its Bristol Dry Lake lithium brine project positioned in the Mojave Desert in California. An article discussing this reads: “Key to the project’s success is the area’s excellent mining infrastructure that tackles the primary challenges facing lithium mining – access and cost-effective production. Through a strategic partnership with two permitted brine operators, National Chloride Corporation of America (NCAA) and TETRA Technologies (TETRA), Standard Lithium has immediate access to conduct exploration brine sampling, evaporation and lithium processing activities, enabling a fast-track project development schedule.”

To view the full article, visit http://dtn.fm/6i3Ll

About Standard Lithium

Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The Company is also commencing due diligence and resource evaluation on 33,000 acres of lithium brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Regains Listing Compliance

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has regained NYSE American listing compliance. The company received a letter on November 9, 2017, from NYSE Regulation stating that it is currently in compliance with the NYSE American LLC continued listing standards set forth in section 704 of the NYSE American Company Guide. This update came on the heels of IGC’s annual meeting, which took place on November 8, 2017. As noted in this morning’s news release, the company’s listing eligibility will continue to be assessed on an ongoing basis moving forward, as is the case for all listed issuers.

To view the full press release, visit http://dtn.fm/ZW7Wu

About IGC

IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information please visit www.igcinc.us

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) at Epicenter of Global Clean Energy Revolution

• World demand for lithium expected to increase 300% by 2025
• Global lithium compounds market projected to reach U.S. $5.87 billion by 2020
• Electric vehicles are on track to take 54% of new car sales by 2040
• Exploration of Bristol Lake Project reveals excellent lithium-bearing brine harvest potential

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF), a Canadian energy exploration and development company, is aggressively working to fill the increasing demand for lithium as it focuses on its Bristol Dry lake lithium brine project located in California’s Mojave Desert. As a junior mining company, Standard Lithium is building one of the largest portfolios of high quality, domestic U.S. lithium brine assets.

Bloomberg New Finance reports the global long-term outlook for electric vehicles is moving faster than the firm predicted a year ago. EVs are on track to accelerate to 54 percent of new car sales by 2040 as more countries around the world seek alternatives to the internal combustion engine and the resulting pollution they cause (http://dtn.fm/bWCd7). In fact, the dynamics at play for lithium growth run the gamut as the future of transportation and energy efficiency accelerate the need for more of the world’s lightest metal.

Standard Lithium’s geophysics team recently concluded a comprehensive gravity survey over the company’s entire Bristol Dry Lake Lithium Project containing 35,000 acres of placer mineral claims and private property. Initial interpretation of the data indicate that high concentrations of lithium-bearing brines are present throughout the company’s mineral lease agreement claims (http://dtn.fm/EoFK0).

Key to the project’s success is the area’s excellent mining infrastructure that tackles the primary challenges facing lithium mining – access and cost-effective production. Through a strategic partnership with two permitted brine operators, National Chloride Corporation of America (NCAA) & TETRA Technologies (TETRA) , Standard Lithium has immediate access to conduct exploration brine sampling, evaporation and lithium processing activities, enabling a fast-track project development schedule.

In addition to the Bristol Lake Brine Project, Standard Lithium has signed a Letter of Intent with a NYSE-listed chemical processing company for 30,000-plus acres of brine leases in the Smackover Formation within southern Arkansas. This brine resource may be one of the lithium industry’s most promising projects to develop (http://dtn.fm/KY3Un), STLHF management believes. As world demand for lithium continues to grow, so does Standard Lithium’s determination to be a major player in the lithium compounds market.

For more information about the company, visit http://nnw.fm/standardlithium

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Progresses in Global Life Sciences Industry

Pressure BioSciences, Inc. (OTCQB: PBIO) is engaged in the development and sale of innovative solutions for the worldwide life sciences industry. The company is advancing in the industry, with its patented high pressure cycling technology. PBIO also recently received patents for its Ultra Shear Technology. An article discussing this reads: “Pressure BioSciences, which completed 2016 with $2 million in sales with only one salesperson on board, has recently added five more people to the sales staff — and the team is diligently working to continue the company’s progress in the industry. Its newest table-top, high-pressure instrument is a finalist in the 2017 R&D 100 Awards, which are often referred to as the “Oscars of Innovation”. Furthermore, key opinion leaders around the globe are beginning to recognize the Barocycler 2320EXT instrument as a “must have” for laboratory research because of the many advantages the instrument has over its competitors, including a new USB output port where data generated by the instrument can be downloaded, making it a useful tool for FDA-required testing in biopharma quality control, a brand new application.”

To view the full article, visit http://dtn.fm/Je233

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.pressurebiosciences.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Takes Aim at $78.4B O2O E-Commerce Market in China

Moxian, Inc. (NASDAQ: MOXC) is an online-to-offline (O2O) integrated platform operator in China. The company offers two apps, Moxian+ User and Moxian+ Business, that enable businesses to reward consumer loyalty in an O2O pipeline. An article discussing this reads: “Retail analyst iResearch estimates this year’s O2O e-commerce sales in China alone will amount to $78.4 billion, driven largely by the “integration of online and offline business” and company strategies aimed at adding value to their offerings amid a 29.6 percent year-over-year growth in online shopping during the second quarter (http://dtn.fm/F3hCq).”

To view the full article, visit http://dtn.fm/KRh3i

About Moxian, Inc.

Founded in 2013 in Shenzhen, China with branch offices in Beijing, Malaysia, and Hong Kong, Moxian, Inc. is an offline-to-online (O2O) integrated platform operator. The company’s “Moxian+” mobile App platform connects users to merchant clients through games, rewards and social events that they enjoy and in return, users provide valuable information that merchant clients can use to effectively promote products and services offered at their brick and mortar stores. For more information, visit the company’s website at www.moxian.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – India Globalization Capital (NYSE: IGC) Avoids Regulatory Costs through Cannabis-based Drug Candidates

India Globalization Capital (NYSE AMERICAN: IGC) is developing a portfolio of products using cannabis-based “combination therapies” for the treatment of various life-altering conditions. The company is employing a distinctive strategy to bring these drug candidates to market. An article discussing this reads: “IGC’s unique strategy reduces regulatory approval time and development costs because its chosen categories face lower regulatory burdens. Instead of pursuing full novel drug applications, which take anywhere from 7-9 years in clinical trials and cost hundreds of millions before securing FDA approval, IGC is developing cannabis-based drugs that could be commercialized in less than two years and at a cost of between $2 million and $3 million per product. These products will then be made available through medical cannabis dispensaries, which means a faster development timeline with a much lower end cost than through the traditional pharmaceutical pipeline.”

To view the full article, visit http://dtn.fm/ZIu2T

About IGC

IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information, visit the company’s website at www.igcinc.us.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)

Atlanta, Georgia

www.MissionIR.com

404.941.8975 Office

Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Moxian, Inc. (NASDAQ: MOXC) Rides Rising Tide of E-Commerce in China

• O2O sales expected to reach $78.4 billion this year in China
• MOXC mobile apps help target nation’s booming e-commerce shopping
• China’s online purchase growth outpacing in-store business

Moxian, Inc. (NASDAQ: MOXC) is helping large retail businesses connect with their customers amid the explosive growth of e-commerce in China, a nation that contains about a fifth of the world’s population and tremendous potential for market success.

Multinational professional services network PricewaterhouseCoopers reported earlier this year that 7 percent of China’s shoppers did their daily shopping by mobile phone and 5 percent using desktop computers — about twice the rate worldwide (http://dtn.fm/0mWB5).  During the first quarter, national online retail sales were 32.1 percent higher than the previous year, whereas in-store sales increased only by 7.2 percent, it reported.

Moxian’s social network-enabled apps Moxian+ User and Moxian+ Business cater to customers and the businesses they frequent, helping businesses reward consumer loyalty in an online-to-offline (O2O) pipeline that personalizes the shopping experience while helping customers geo-locate the nearest store for the products they’re seeking at any given time.

The app also builds on social media trends by allowing users to interact with a circle of online friends, share information through groups or topic messaging and personalize their networks.

The Shenzhen, China-based development-stage company announced a change in direction in October to focus its resources on corporate clients with large retail footprints whose mobile customers may be seeking them at a variety of locations on a given day.

MOXC’s new CEO and board undertook the measure amid a shift from a free app model to a paid subscription service, after determining the larger retailers will provide a greater market share at a faster pace than the multitude of small mom-and-pop shops that may have a limited number of locations.

The company’s change in strategy also aims to reduce non-production related SG&A costs by boosting sales through independent agents, which will help Moxian better align its costs with the customer revenue stream, according to the company (http://dtn.fm/95UAf).

China Daily reported that the first half of 2017 saw retail sales climb 10.4 percent to some 17.24 trillion yuan ($2.55 trillion), and a 28.6 percent increase in the online sale of physical goods (http://dtn.fm/6ChWh).

Retail analyst iResearch estimates this year’s O2O e-commerce sales in China alone will amount to $78.4 billion, driven largely by the “integration of online and offline business” and company strategies aimed at adding value to their offerings amid a 29.6 year-over-year growth in online shopping during the second quarter (http://dtn.fm/CW5jg).

Moxian’s apps provide companies with data to help them better target those digital consumers and develop repeat business at their stores. In 2016, the Big Data Industry Alliance of China and the China Center for Information Industry Development presented the company with an award for Best Solution Award of Social Media Marketing.

For more information, visit the company’s website at www.Moxian.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Alters Business Strategy After Recently Appointing a New CEO

In September, Moxian, Inc. (NASDAQ: MOXC) announced that Hao Qing Hu was named the company’s new chief executive officer. As the leadership changed, so did the company’s strategy. The company is now focused on larger retailers in China and how to help these clients secure more customers. An article discussing this reads: “Less than a month after announcing (http://dtn.fm/EtU9g) that Hao Qing Hu would take over the reins as chief executive officer of Moxian, Inc. (NASDAQ: MOXC), the company’s data-driven Social Customer Relationship Management system has begun shifting its focus toward helping large retailers build reward incentives to draw customers into their stores (http://dtn.fm/tS4KY).”

To view the full article, visit http://dtn.fm/X3bi1

About Moxian, Inc.

Founded in 2013 in Shenzhen, China with branch offices in Beijing, Malaysia, and Hong Kong, Moxian, Inc. is an offline-to-online (O2O) integrated platform operator. The company’s “Moxian+” mobile App platform connects users to merchant clients through games, rewards and social events that they enjoy and in return, users provide valuable information that merchant clients can use to effectively promote products and services offered at their brick and mortar stores. For more information, visit the company’s website at www.moxian.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html